Jane R. Parnes

Tezepelumab in Adults with Uncontrolled Asthma

Jonathan Corren, Jane R. Parnes, May Mo et al. · New England Journal of Medicine · 2017 · 938 citations · Full text

Life Sciences, Immunology, Internal Medicine +16

Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses

Gail M. Gauvreau, Paul M. O’Byrne, Louis‐Philippe Boulet et al. · New England Journal of Medicine · 2014 · 780 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Identification of CD72 as a Lymphocyte Receptor for the Class IV Semaphorin CD100

Atsushi Kumanogoh, Chie Watanabe, Ihn-Sook Lee et al. · Immunity · 2000 · 363 citations · Full text

Life Sciences, Cell Biology, Immunology +10

Tezepelumab, an anti–thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial

Eric L. Simpson, Jane R. Parnes, Dewei She et al. · Journal of the American Academy of Dermatology · 2018 · 320 citations · Full text

Life Sciences, Dermatology, Immunology +17

Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial

Sarah Diver, Latifa Khalfaoui, Claire Emson et al. · The Lancet Respiratory Medicine · 2021 · 314 citations

Pharmacy, Immunology, Pharmacotherapy +12